Literature DB >> 30959160

Important roles of protein tyrosine phosphatase PTPN12 in tumor progression.

Chaelin Lee1, Inmoo Rhee2.   

Abstract

Protein tyrosine phosphatases (PTPs), which are ubiquitously expressed in hematopoietic and non-hematopoietic cells, are critical for regulating cell proliferation as well as differentiation in the physiology of multicellular organisms. PTPs regulate the intracellular signaling mechanism of immune cells via dephosphorylation of multiple targets and are associated with the onset of various autoimmune diseases through genomic alterations. PTPs also affect disease through their role in innate and/or acquired immunity. By modulating multiple substrates, PTPN12, a member of the proline-, glutamic acid-, serine- and threonine-rich (PEST) family of PTPs, is an important regulator of cell migration and adhesion. According to its newly identified roles and functions, PTPN12 is considered a promising therapeutic target against critical diseases, including cancer, diabetes, metabolic disease and autoimmune diseases. In this review, we provide an overview of PTPs and discuss the critical roles of PTPN12/PTP-PEST in tumor progression.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aplidin (CID: 9812534); Breast cancer; Chemical compounds studied in this article; Dephostatin (CID: 2990); Gallium nitrate (CID: 61635); Inhibitors; MSI-1436 (CID: 9917968); PTPN12/PTP-PEST; Phenylarsine oxide (CID: 131726110); Phosphorylation; Protein tyrosine phosphatases; RMC-4550 (CID: 134183206); SHP099 (CID: 118238298); Signal transduction; Sodium stibogluconate (CID: 16683013); Suramin (CID: 5361); Vanadate (CID: 61672)

Mesh:

Substances:

Year:  2019        PMID: 30959160     DOI: 10.1016/j.phrs.2019.04.011

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

1.  BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale.

Authors:  Jillian Wilhelmina Paulina Bracht; Niki Karachaliou; Trever Bivona; Richard B Lanman; Iris Faull; Rebecca J Nagy; Ana Drozdowskyj; Jordi Berenguer; Manuel Fernandez-Bruno; Miguel Angel Molina-Vila; Rafael Rosell
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

2.  Evaluating Large Spontaneous Deletions in a Bovine Cell Line Selected for Bovine Viral Diarrhea Virus Resistance.

Authors:  Aspen M Workman; Michael P Heaton; Dennis A Webster; Gregory P Harhay; Theodore S Kalbfleisch; Timothy P L Smith; Shollie M Falkenberg; Daniel F Carlson; Tad S Sonstegard
Journal:  Viruses       Date:  2021-10-25       Impact factor: 5.048

3.  PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis.

Authors:  Wenbin Kuang; Xiao Wang; Jiayu Ding; Jiaxing Li; Minghui Ji; Weijiao Chen; Liping Wang; Peng Yang
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

Review 4.  Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy.

Authors:  Xiaolong Tang; Chumei Qi; Honghong Zhou; Yongshuo Liu
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

5.  Transthyretin-induced increase in circ_0007411 represses neovascularization of human retinal microvascular endothelial cells in hyperglycemia via the miR-548m/PTPN12/SKP1/EGFR pathway.

Authors:  Di Hu; Yikun Tian; Lu Ye; Yu Xin; Jun Shao
Journal:  Ann Transl Med       Date:  2022-05

Review 6.  Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity.

Authors:  Poojitha Sitaram; Bradley Uyemura; Subramaniam Malarkannan; Matthew J Riese
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

7.  Progress in the correlation between PTPN12 gene expression and human tumors.

Authors:  Yu-Hu Huo; Ya-Ni Wang; Ling-Bing Meng; Ai-Li Zhang; Bin Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.